RNS Announcement

RNS Number : 3553Z
Volex PLC
07 April 2026
 

Description: Volex Logo Black

 

LEI: 213800HBLQNH5FXXGE63

7 April 2026

Volex plc

("Volex", the "Company", or the "Group")

Update on Move to the Main Market

 

Volex plc (AIM: VLX), the specialist integrated manufacturer of critical power and data transmission products, today provides an update on its proposed move to the Main Market.

 

Confirmation of intention to move from AIM to the Main Market

 

Further to the announcement of 25 March 2026, and following consultation with the Company's largest shareholders, the Board of Volex today confirms its intention to apply to the Financial Conduct Authority (the "FCA") for admission of all of the Company's ordinary shares of 25 pence each (the "Ordinary Shares") to the equity shares (commercial companies) category of the Official List of the FCA, and to trading on the Main Market of London Stock Exchange plc (the "London Stock Exchange") ("Admission").

 

Admission is subject to the approval by the FCA of a prospectus, its admission of the Ordinary Shares to listing on the Official List, and admission by the London Stock Exchange of the Ordinary Shares to trading on the Main Market. Admission is not conditional upon shareholder approval. The Company is targeting Admission prior to 4 August 2026 (being the date by which Admission must be effective in order to meet the 20 day minimum trading requirement to be eligible for inclusion in the FTSE Russell's September 2026 Quarterly Review of the FTSE 250 Index). On and subject to Admission occurring, the Company's listing on AIM will be cancelled.  Shareholders should note that the Company's shares will no longer be traded on AIM with effect from Admission and should consult their own professional advisers regarding the consequences of Admission.

 

The Company will provide a further update on the timeline and process through to Admission in due course.

 

Launch of share buyback programme

 

Volex has also announced today that the Board has approved and launched a share buyback programme to return up to £40 million to shareholders, further details of which are set out in a separate announcement.

 

Capital Markets Event

 

As previously announced, Volex will host a Capital Markets Event for institutional investors and analysts at 14.00 on Wednesday 22 April 2026 at the offices of Peel Hunt LLP, 100 Liverpool Street, London. The event will set out the Company's new medium-term growth targets.

 

Institutional investors who are interested in attending in person should contact Sodali at Volex@sodali.com.

 

 

-ENDS-

 

For further information please contact:

 

Volex plc


44 (0) 1256 442570

Nat Rothschild, Chief Executive Officer                 


investor.relations@volex.com

Jon Boaden, Chief Financial Officer






Peel Hunt LLP - Nominated Adviser & Joint Broker


44 (0) 20 7418 8900

Ed Allsopp



Dom Convey



Charlotte Sutcliffe



Tom Graham






Jefferies - Joint Broker


44 (0) 20 7029 8000

Philip Noblet



Sam Barnett



Harry Le May






Sodali & Co. - Media Enquiries


44 (0) 20 7250 1446

James White



Nicholas Johnson



 

About Volex plc

Volex plc (AIM:VLX) is a driving force in integrated manufacturing for mission-critical applications and a global leader in power and data connectivity solutions. Our diverse operations support international blue-chip customers in five key end-markets: Electric Vehicles, Consumer Electricals, Medical, Complex Industrial Technology and Off-Highway. Headquartered in the UK, we orchestrate operations across 23 advanced manufacturing facilities, uniting 13,000 dynamic individuals from 25 different nations. Our extraordinary products find their way to market through our localised sales teams and authorised distributor partners, supporting Original Equipment Manufacturers and Electronic Manufacturing Services companies across the globe. In a world that grows more digitally complex by the day, customers trust us to deliver power and connectivity that drives everything from household essentials to life-saving medical equipment. Learn more at www.volex.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSSAFMMEMSEDL